# TReatment of Pulmonary Hypertension Group II Study

> **NCT03611270** · NA · ACTIVE_NOT_RECRUITING · sponsor: **SoniVie Inc.** · enrollment: 15 (estimated)

## Conditions studied

- Pulmonary Hypertension (PH) Due to Left Heart Disease

## Interventions

- **DEVICE:** Pulmonary Denervation

## Key facts

- **NCT ID:** NCT03611270
- **Lead sponsor:** SoniVie Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-11-30
- **Primary completion:** 2023-12-01
- **Final completion:** 2027-07
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2023-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03611270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03611270, "TReatment of Pulmonary Hypertension Group II Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03611270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*